GlassScriptPhysician profile
Eric S Palosky
NPI 1174718001
$6,641.66
in general payments reported to CMS, 2019-2025
50 companies · $253 in 2025
The $253 reported for 2025 was more than what a typical Family Medicine provider received nationally (typical 2025 total: $153).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $1,174 · 2020: $1,559 · 2021: $1,266 · 2022: $829 · 2023: $950 · 2024: $612 · 2025: $253.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,815.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,814.73 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Novo Nordisk INC | $1,242.87 | 2019-2024 | Ozempic, Rybelsus |
| Astrazeneca Pharmaceuticals LP | $889.83 | 2019-2025 | Farxiga, Airsupra, Breztri |
| Glaxosmithkline, LLC. | $570.85 | 2019-2025 | Trelegy Ellipta |
| Lilly USA, LLC | $432.85 | 2019-2024 | Mounjaro, Trulicity |
| Abbvie INC. | $410.82 | 2020-2025 | |
| Merck Sharp & Dohme LLC | $332.25 | 2019-2022 | |
| Pfizer INC. | $230.09 | 2019-2024 | |
| Amgen INC. | $208.02 | 2019-2025 | Repatha, Otezla, Otezla |
| Exact Sciences Corporation | $172.32 | 2023-2025 | Cologuard Collection Kit, The Cologuard Plus Collection Kit |
| Astellas Pharma US INC | $144.99 | 2019-2021 | |
| Bayer Healthcare Pharmaceuticals INC. | $143.13 | 2021-2024 | |
| Idorsia Pharmaceuticals US INC | $134.16 | 2022-2024 | Quviviq |
| Alnylam Pharmaceuticals INC. | $129.78 | 2022-2023 | Onpattro |
| Evoke Pharma, INC. | $124.25 | 2020-2022 | |
| Sanofi-Aventis U.S. LLC | $107.62 | 2019-2022 |
Show all 50 companies
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Eric Palosky listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.